Cash Cash Equivalents - ADC Therapeutics SA (NYSE:ADCT) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 4.76 USD -4.03%

Updated:

ADC Therapeutics SA
Cash & Cash Equivalents

Last Value

3-Years CAGR

5-Years CAGR

Quarterly

Annual

|

Adjust for Inflation

ADC Therapeutics SA
Cash & Cash Equivalents Peer Comparison

ACIU

CRSP

BSLN

IDIA

KURN

Company		Cash & Cash Equivalents	CAGR 3Y	CAGR 5Y	CAGR 10Y
	ADC Therapeutics SA NYSE:ADCT	Cash & Cash Equivalents $278.6m	CAGR 3-Years -14%	CAGR 5-Years 15%	CAGR 10-Years N/A
	AC Immune SA NASDAQ:ACIU	Cash & Cash Equivalents CHf78.5m	CAGR 3-Years -21%	CAGR 5-Years -13%	CAGR 10-Years N/A
	CRISPR Therapeutics AG NASDAQ:CRSP	Cash & Cash Equivalents $389.5m	CAGR 3-Years -31%	CAGR 5-Years -3%	CAGR 10-Years N/A
	Basilea Pharmaceutica AG SIX:BSLN	Cash & Cash Equivalents CHf59.9m	CAGR 3-Years 0%	CAGR 5-Years -19%	CAGR 10-Years -7%
	Idorsia Ltd SIX:IDIA	Cash & Cash Equivalents CHf146m	CAGR 3-Years -18%	CAGR 5-Years -25%	CAGR 10-Years N/A
	Kuros Biosciences AG SIX:KURN	Cash & Cash Equivalents CHf14.2m	CAGR 3-Years -21%	CAGR 5-Years -5%	CAGR 10-Years N/A

See Also

Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Cash & Cash Equivalents amounts to 278.6m USD.

Over the last year, the Cash & Cash Equivalents growth was -15%. The average annual Cash & Cash Equivalents growth rates for ADC Therapeutics SA have been -14% over the past three years , 15% over the past five years .

Join more than 129,100+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.